CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Rare Diseases (230)
OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera's intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with b...Show all
Company (Alive / Active)
Phone: +46 8 660 02 23
Regeringsgatan 111
Stockholm, 111 39
Sweden
| Total Funding | Date of Last Funding | |
|---|---|---|
| OxThera | $53.7M | Nov 29, 2016 |
| Cerecin | $247.9M | Oct 4, 2018 |
| Arcion Therapeutics | $17M | Oct 1, 2012 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes | Dec 12, 2014 | Dec 05, 2017 | Patent |
| Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes | Mar 27, 2013 | Jan 27, 2015 | Patent |
| Compositions and methods for oxalate reduction | Dec 15, 2006 | Dec 02, 2014 | Patent |
| Pharmaceutical compositions and methods for treating oxalate-dependent conditions | Dec 14, 2006 | Oct 01, 2013 | Patent |
| Compositions and methods for treating or preventing oxalate-related disease | Jun 15, 2004 | Jul 16, 2013 | Patent |
